Javascript must be enabled to continue!
American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner
View through CrossRef
ABSTRACTThe 6th Guidelines on the use of therapeutic apheresis in clinical practice published by the American Society of Apheresis provide practical, concise, and evidence based guidance for the apheresis medicine practitioner. The overall format of the Guidelines has remained unchanged with the 6th edition, compared to the 5th edition, with enhancements in the committee process of creating the guidelines. Because of changes in the writing committee structure, a number of changes have occurred in the ASFA category and recommendation grade for the use of apheresis in the treatment for a number of previously categorized clinical indications. In addition, eight new indications for apheresis, twenty three new clinical situations for previously categorized diseases, and ten new apheresis treatments for previously categorized disorders have been added. The 6th Guidelines continue to be an invaluable resource for those involved in apheresis medicine. J. Clin. Apheresis 29:191–193, 2014. © 2014 Wiley Periodicals, Inc.
Title: American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner
Description:
ABSTRACTThe 6th Guidelines on the use of therapeutic apheresis in clinical practice published by the American Society of Apheresis provide practical, concise, and evidence based guidance for the apheresis medicine practitioner.
The overall format of the Guidelines has remained unchanged with the 6th edition, compared to the 5th edition, with enhancements in the committee process of creating the guidelines.
Because of changes in the writing committee structure, a number of changes have occurred in the ASFA category and recommendation grade for the use of apheresis in the treatment for a number of previously categorized clinical indications.
In addition, eight new indications for apheresis, twenty three new clinical situations for previously categorized diseases, and ten new apheresis treatments for previously categorized disorders have been added.
The 6th Guidelines continue to be an invaluable resource for those involved in apheresis medicine.
J.
Clin.
Apheresis 29:191–193, 2014.
© 2014 Wiley Periodicals, Inc.
Related Results
Overview on LDL‐apheresis in cardiovascular diseases
Overview on LDL‐apheresis in cardiovascular diseases
LDL apheresis has been widely accepted as an effective treatment for hypercholesterolemic patients who are resistant to drug and conventional therapy such as in case of familial hy...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis
Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis
AbstractThe quality of evidence supporting the use of apheresis in the treatment of individual diseases and disorders is often limited. For most diseases and disorders, randomized ...
Evaluation of the Level of Evidence Supporting the Recommendations Constituting the American Academy of Dermatology Clinical Practice Guidelines: Cross-Sectional Analysis (Preprint)
Evaluation of the Level of Evidence Supporting the Recommendations Constituting the American Academy of Dermatology Clinical Practice Guidelines: Cross-Sectional Analysis (Preprint)
BACKGROUND
Clinical practice guidelines are evidence-based recommendations used by physicians to improve patient care. These guidelines provide the physicia...
Randomized controlled trials in therapeutic apheresis
Randomized controlled trials in therapeutic apheresis
The literature on the use of therapeutic apheresis is often criticized for the preponderance of low to very low quality evidence. Shehata et al. examined the apheresis literature p...
Low‐Density Lipoprotein Apheresis Decreases Ferritin, Transferrin and Vitamin B12, Which May Cause Anemia in Serially Treated Patients
Low‐Density Lipoprotein Apheresis Decreases Ferritin, Transferrin and Vitamin B12, Which May Cause Anemia in Serially Treated Patients
AbstractClinical observations revealed an increased prevalence of iron deficiency anemia without chronic bleeding in patients treated with serial low‐density lipoprotein (LDL) aphe...
Therapeutic apheresis in renal transplantation; current practices
Therapeutic apheresis in renal transplantation; current practices
Apheresis is an important treatment modality for the removal of pathologic antibodies and circulating proteins in kidney transplantation. The use of apheresis has been shown to be ...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...

